Astellas Establishes Venture Management Company in US.Tokyo, Japan, Jan 27, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Astellas Pharma Astellas Pharma Inc. (アステラス製薬株式会社 announced on January 27 that the company has established Astellas Venture Management LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control (AVM AVM 1 Acute viral meningitis, see there 2 Arteriovenous malformation, see there ) in California. Capitalized at $67.5 million, AVM manages all venture investment business of former Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical as well as newly established limited partnership Astellas Venture Fund I L.P. AVM will discover venture companies with proprietary technologies and help them grow by utilizing Astellas' experience in and network of its biotechnology business. AVM will offer entrepreneurial venture firms not only investment funds but also the Astellas group's scientific and technical expertise, depth of drug development and marketing knowledge and long-term business perspective. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion